Since diacylglycerol has been shown to reduce atherosclerosis in an APOE-deficient mouse model [17], the increase in diacylglycerol in the ε4 genotype could be a compensatory mechanism to combat rising levels of atherosclerosis. This evidence concerns the gene APOE and atherosclerosis.